FDA approves medicine for treatment of deep vein thrombosis

Share this article:
FDA approves medicine for treatment of deep vein thrombosis
FDA approves medicine for treatment of deep vein thrombosis

The Food and Drug Administration has approved Janssen Pharmaceuticals, Inc.'s Xarelto (rivaroxaban ). Xarelto is intended for the treatment of deep vein thrombosis (DVT). If all or part of a DVT breaks off, it can travel to and lodge in the lungs, and can lead to potentially life-threatening consequences.


Share this article:

More in Products

More vendors see value in video-based marketing

A growing number of business-to-business marketers have begun using videos to get their message across, according to a survey sponsored by Vidyard and conducted by Demand Metric.

Meals on wheels may never be the same

Meals on wheels may never be the same

As facilities struggle to staff, help may soon be available in the form of a meal-delivering robot.

An app for residents who've fallen and can't get up

An app for residents who've fallen and can't ...

Philips just released a one-touch app for seniors who have fallen and can't get up.